| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1033796636 |
| P356 | DOI | 10.1186/S13027-016-0052-2 |
| P932 | PMC publication ID | 4748452 |
| P698 | PubMed publication ID | 26865856 |
| P5875 | ResearchGate publication ID | 293014173 |
| P50 | author | Soren Gantt | Q42647995 |
| Meei-Li Huang | Q61713476 | ||
| Anna Wald | Q41122225 | ||
| Connie Celum | Q42571941 | ||
| P2093 | author name string | Corey Casper | |
| R Scott McClelland | |||
| Joshua T Schiffer | |||
| Stacy Selke | |||
| Christine Johnston | |||
| Amalia S Magaret | |||
| Jason D Goldman | |||
| Larry Corey | |||
| Richard A Zuckerman | |||
| Rachel A Bender Ignacio | |||
| Warren T Phipps | |||
| P2860 | cites work | Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons | Q43704029 |
| Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factors | Q44032584 | ||
| Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention | Q44898746 | ||
| Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates | Q45117910 | ||
| Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial | Q45399240 | ||
| PCR detection of Epstein-Barr virus, herpes simplex virus and human papillomavirus from the anal mucosa in HIV-seropositive and HIV-seronegative homosexual men. | Q45747151 | ||
| Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial | Q45758637 | ||
| Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. | Q45769785 | ||
| Shedding of human herpesvirus 8 in oral and genital secretions from HIV-1-seropositive and -seronegative Kenyan women. | Q46821042 | ||
| Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors | Q47688207 | ||
| Cytomegalovirus (CMV) shedding is highly correlated with markers of immunosuppression in CMV-seropositive women | Q57235786 | ||
| Antibodies to human herpesvirus 8 in women and infants born in Haiti and the USA | Q73336390 | ||
| Human herpesvirus 8 oral shedding in HIV-infected men with and without Kaposi sarcoma | Q79767779 | ||
| Human herpesvirus 8 seropositivity among sexually active adults in Uganda | Q28743392 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease | Q29619158 | ||
| Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs | Q32075378 | ||
| Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda | Q33401242 | ||
| Reduced human herpesvirus-8 oropharyngeal shedding associated with protease inhibitor-based antiretroviral therapy | Q33610926 | ||
| Frequent genital HSV-2 shedding among women during labor in Soweto, South Africa | Q33745846 | ||
| Mucosal shedding of human herpesvirus 8 in men. | Q33924644 | ||
| Quantitative stability of DNA after extended storage of clinical specimens as determined by real-time PCR. | Q33963010 | ||
| Imiquimod 5-percent cream does not alter the natural history of recurrent herpes genitalis: a phase II, randomized, double-blind, placebo-controlled study | Q34144914 | ||
| Assessment of a combined testing strategy for detection of antibodies to human herpesvirus 8 (HHV-8) in persons with Kaposi's sarcoma, persons with asymptomatic HHV-8 infection, and persons at low risk for HHV-8 infection | Q34193434 | ||
| Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes | Q34279175 | ||
| HHV-8 infection: a model for reactivation and transmission | Q34490261 | ||
| HIV infection and human herpesvirus-8 oral shedding among men who have sex with men. | Q34547024 | ||
| Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen | Q34735858 | ||
| Oral HHV-8 replication among women in Mombasa, Kenya | Q34901897 | ||
| The kinetics of mucosal herpes simplex virus-2 infection in humans: evidence for rapid viral-host interactions | Q35129410 | ||
| Patterns of herpes simplex virus shedding over 1 month and the impact of acyclovir and HIV in HSV-2-seropositive women in Tanzania | Q35740472 | ||
| Optimizing PCR positivity criterion for detection of herpes simplex virus DNA on skin and mucosa | Q35784428 | ||
| Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV-MCD) and the KSHV Inflammatory Cytokine Syndrome | Q35795414 | ||
| Frequent and asymptomatic oropharyngeal shedding of human herpesvirus 8 among immunocompetent men. | Q36247828 | ||
| Treatment with valacyclovir, famciclovir, or antiretrovirals reduces human herpesvirus-8 replication in HIV-1 seropositive men. | Q36301349 | ||
| High Rate of β-Globin DNA Detection Validates Self-Sampling in Herpes Simplex Virus Shedding Studies | Q36716793 | ||
| Transmission of human herpesvirus 8: an update | Q36819145 | ||
| Phase I study of a herpes simplex virus type 2 (HSV-2) DNA vaccine administered to healthy, HSV-2-seronegative adults by a needle-free injection system | Q36974311 | ||
| Population-based assessment of kaposi sarcoma-associated herpesvirus DNA in plasma among Ugandans | Q37128291 | ||
| Use of the designation "shedder" in mucosal detection of herpes simplex virus DNA involving repeated sampling | Q37315449 | ||
| Global estimates of cancer prevalence for 27 sites in the adult population in 2008. | Q38920305 | ||
| Comparative study of Kaposi's sarcoma-associated herpesvirus serological assays using clinically and serologically defined reference standards and latent class analysis | Q39294399 | ||
| Consistent viral DNA quantification after prolonged storage at ambient temperature | Q40893300 | ||
| Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma | Q40972068 | ||
| P304 | page(s) | 7 | |
| P577 | publication date | 2016-02-10 | |
| P1433 | published in | Infectious Agents and Cancer | Q15814259 |
| P1476 | title | Patterns of human herpesvirus-8 oral shedding among diverse cohorts of human herpesvirus-8 seropositive persons | |
| P478 | volume | 11 |
| Q39190555 | Diagnosis and Treatment of Kaposi Sarcoma |
| Q56929430 | HHV-8 Seroprevalence and Genotype Distribution in Africa, 1998–2017: A Systematic Review |
| Q89685627 | HIV-associated exosomes promote infection of Kaposi sarcoma-associated herpesvirus via epidermal growth factor receptor |
| Q50099317 | KSHV oral shedding and plasma viremia result in significant changes in the extracellular tumorigenic miRNA expression profile in individuals infected with the malaria parasite |
| Q38717700 | No detectable human herpesvirus-8 oral shedding in seronegative-healthy, immunocompetent individuals from non-endemic regions for Kaposi's sarcoma: A pilot study |
| Q45325522 | Prospective study of human herpesvirus 8 oral shedding, viremia, and serological status among human immunodeficiency virus seropositive and seronegative individuals in Sao Paulo, Brazil |
| Q90295076 | Risk factors for Kaposi's sarcoma associated herpesvirus (KSHV) DNA in blood and in saliva in rural Uganda |
Search more.